Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-22

Clinical Trial Update: Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer [Phase 1]

View source ↗

Summary

Phase I clinical trial update for CEA-specific AAV-DC-CTL therapy in stage IV gastric cancer. The study is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEA Specific AAV-DC-CTL

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Gastric Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING